These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1263740

  • 1. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
    Magour S, Coper H, Fähndrich C, Hill R.
    Life Sci; 1976 Mar 15; 18(6):575-84. PubMed ID: 1263740
    [No Abstract] [Full Text] [Related]

  • 2. Subcellular distribution of delta9-tetrahydrocannabinol in rat brain.
    Colburn RW, Ng LK, Lemberger L, Kopin IJ.
    Biochem Pharmacol; 1974 Feb 15; 23(4):873-7. PubMed ID: 4824510
    [No Abstract] [Full Text] [Related]

  • 3. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions.
    Sarkar C, Ghosh JJ.
    J Neurochem; 1975 Feb 15; 24(2):381-5. PubMed ID: 1113115
    [No Abstract] [Full Text] [Related]

  • 4. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW, Lawrence DK.
    J Pharm Pharmacol; 1973 Dec 15; 25(12):948-52. PubMed ID: 4150297
    [No Abstract] [Full Text] [Related]

  • 5. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW, Jones G, Lawrence DK.
    Biochem Pharmacol; 1973 Jan 15; 22(2):175-84. PubMed ID: 4763251
    [No Abstract] [Full Text] [Related]

  • 6. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z, Mechoulam R, Edery H, Porath G.
    Science; 1971 Nov 26; 174(4012):951-2. PubMed ID: 5001309
    [Abstract] [Full Text] [Related]

  • 7. Effect of delta-9-tetrahydrocannabinol on gangliosides and sialoglycoproteins in subcellular fractions of rat brain.
    Sarkar C, Ghosh JJ.
    J Neurochem; 1976 Apr 26; 26(4):721-3. PubMed ID: 965964
    [No Abstract] [Full Text] [Related]

  • 8. Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.
    Magour S, Coper H, Fähndrich C.
    Psychopharmacology (Berl); 1977 Jan 31; 51(2):141-5. PubMed ID: 402665
    [Abstract] [Full Text] [Related]

  • 9. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK, Pertwee RG.
    Br J Pharmacol; 1973 Oct 31; 49(2):373-5. PubMed ID: 4793443
    [Abstract] [Full Text] [Related]

  • 10. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW, Lawrence DK.
    Biochem Pharmacol; 1974 Mar 15; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract] [Full Text] [Related]

  • 11. 9-Nor-delta8-tetrahydrocannabinol, a cannabinoid of metabolic interest.
    Wilson RS, May EL.
    J Med Chem; 1974 Apr 15; 17(4):475-6. PubMed ID: 4830548
    [No Abstract] [Full Text] [Related]

  • 12. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment.
    Mantilla-Plata B, Harbison RD.
    Toxicol Appl Pharmacol; 1975 Nov 15; 34(2):292-300. PubMed ID: 1209626
    [No Abstract] [Full Text] [Related]

  • 13. The membrane binding of morphine, diphenylhydantoin, and tetrahydrocannabinol.
    Seeman P, Chau-Wong M, Moyyen S.
    Can J Physiol Pharmacol; 1972 Dec 15; 50(12):1193-200. PubMed ID: 4655051
    [No Abstract] [Full Text] [Related]

  • 14. Delta-9-tetrahydrocannabinol: localization in body fat.
    Kreuz DS, Axelrod J.
    Science; 1973 Jan 26; 179(4071):391-3. PubMed ID: 4682965
    [Abstract] [Full Text] [Related]

  • 15. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
    McCallum ND, Yagen B, Levy S, Mechoulam R.
    Experientia; 1975 May 15; 31(5):520-1. PubMed ID: 1140243
    [No Abstract] [Full Text] [Related]

  • 16. The facilitating and suppressing effects of delta 9-tetrahydrocannabinol on the rise in intrasynaptosomal Ca2+ concentration in rats.
    Okada M, Urae A, Mine K, Shoyama Y, Iwasaki K, Fujiwara M.
    Neurosci Lett; 1992 Jun 08; 140(1):55-8. PubMed ID: 1328966
    [Abstract] [Full Text] [Related]

  • 17. Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
    Fernandes M, Schabarek A, Coper H, Hill R.
    Psychopharmacologia; 1974 Jun 08; 38(4):329-38. PubMed ID: 4473791
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
    Farrow JT, Van Vunakis H.
    Biochem Pharmacol; 1973 May 01; 22(9):1103-13. PubMed ID: 4695669
    [No Abstract] [Full Text] [Related]

  • 19. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A, Glowa J, Herkenham M.
    Brain Res; 1993 Jul 09; 616(1-2):293-302. PubMed ID: 8395305
    [Abstract] [Full Text] [Related]

  • 20. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
    Levy S, McCallum NK.
    Experientia; 1975 Nov 15; 31(11):1268-9. PubMed ID: 1204768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.